Supreme Court May Decide Whether “Reverse Payment” Settlements Violate Antitrust Law

Patent litigation in the pharmaceutical industry impacts billions of dollars in pharmaceutical sales annually. Cases often involve a brand name drug manufacturer seeking to stop a competitor from selling a generic version of the brand name’s drug. In some cases, the parties reach a settlement that includes a delay in the generic entry date and some monetary consideration from the brand name manufacturer.

Read More: Supreme Court May Decide Whether "Reverse Payment" Settlements Violate Antitrust Law

Download PDF Back To Listing
Loading data